Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib Malate in HER2-negative Metastatic Breast Cancer
NCT01653574Phase 2Completed
- Sponsor
- Fudan University
- Start
- May 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famitinib in breast cancer, sponsored by Fudan University. Started May 2012; status: completed.
02
Drugs
famitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01653574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653574.